LORCET-HD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lorcet-hd, and when can generic versions of Lorcet-hd launch?
Lorcet-hd is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in LORCET-HD is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LORCET-HD?
- What are the global sales for LORCET-HD?
- What is Average Wholesale Price for LORCET-HD?
Summary for LORCET-HD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | LORCET-HD at DailyMed |
US Patents and Regulatory Information for LORCET-HD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | LORCET-HD | acetaminophen; hydrocodone bitartrate | CAPSULE;ORAL | 087336-001 | Jul 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
